Azathramycin A: Macrolide Antibiotic and Ribosome Inhibitor for Tuberculosis Research

Executive Summary: Azathramycin A (CAS No. 76801-85-9) is a macrolide antibiotic that inhibits bacterial protein synthesis by binding the ribosome of Mycobacterium tuberculosis (Mtb), disrupting translation and demonstrating potent antibacterial effects (Jia et al., 2024, DOI). It is primarily used in research on antibacterial mechanisms and TB infection models, with high solubility in DMSO (≥52.8 mg/mL) and ethanol (≥47.4 mg/mL), but is insoluble in water and unstable in solution (APExBIO, product page). Azathramycin A is a major degradation product and impurity of Azithromycin, providing a tool for antibiotic resistance studies. APExBIO supplies Azathramycin A as a solid compound for laboratory use. Resistance to macrolides in mycoplasmas is increasing, highlighting the need for novel ribosome-targeting antibiotics (Jia et al., 2024).

Biological Rationale

Macrolide antibiotics, including Azathramycin A, target the 50S subunit of bacterial ribosomes and inhibit protein synthesis. Mycobacterium tuberculosis is the etiological agent of tuberculosis, a disease causing over 1.5 million deaths annually (WHO, 2023). The emergence of antibiotic-resistant TB strains necessitates new agents with distinct mechanisms, such as ribosomal inhibition (Jia et al., 2024). Azathramycin A was identified as a principal impurity of Azithromycin, itself a widely used macrolide (
APExBIO dossier). Unlike beta-lactams, macrolides are effective against organisms lacking a cell wall, such as mycoplasmas and Mtb. Resistance to macrolides, particularly via the A2063G mutation in 23S rRNA, is rising in clinical isolates (Jia et al., 2024).

Mechanism of Action of Azathramycin A

Azathramycin A binds specifically to the 50S ribosomal subunit of Mycobacterium tuberculosis (related article). This binding blocks the peptidyl transferase center, arresting elongation during translation and halting bacterial protein synthesis (01Jia et al., 2024). The interaction is analogous to other macrolides, such as erythromycin and azithromycin, but Azathramycin A is distinguished by its identification as a degradation product with unique physicochemical parameters: molecular weight 734.96, formula C₃₇H₇₀N₂O₁₂, and enhanced solubility in DMSO and ethanol (01APExBIO). In in vitro biophysical screenings, it exhibits strong ribosome binding affinity and is inactive in the absence of bacterial ribosomes. The protein synthesis inhibition pathway is central to its antibacterial effect (01see advanced insights).

Evidence & Benchmarks

• Azathramycin A inhibits protein synthesis in Mycobacterium tuberculosis by binding the 50S ribosomal subunit, confirmed by in vitro biophysical screening (Jia et al., 2024).
• It is a main impurity and degradation product of Azithromycin, identified during stability and purity analysis (APExBIO).
• Resistance to macrolide antibiotics, including Azathramycin A analogs, is mediated by mutations such as A2063G in 23S rRNA, present in 100% of recent Beijing clinical isolates (Jia et al., 2024).
• The minimum inhibitory concentration (MIC) of 16-membered macrolides is lower than that of 14- or 15-membered macrolides in resistant Mycoplasma pneumoniae strains (Table 2, Jia et al., 2024).
• Azathramycin A is highly soluble in DMSO (0101010152.8 mg/mL) and ethanol (0101010147.4 mg/mL), but insoluble in water (01APExBIO).
• Long-term storage of dissolved Azathramycin A is not recommended due to solution instability; solid should be kept at 012001C (01APExBIO).

This article updates and extends previous mechanistic reviews by providing focused evidence on impurity status and storage constraints for bench-top studies.

Applications, Limits & Misconceptions

Azathramycin A is used in research on antibacterial mechanisms, ribosome-targeting antibiotics, and tuberculosis infection models (see prior article). It is suitable for studies investigating protein synthesis inhibition and ribosome antibiotic resistance pathways (related article). As a ribosome binder, it enables mechanistic dissection of translation inhibition.

Common Pitfalls or Misconceptions

• Azathramycin A is not soluble in water; attempts to dissolve in aqueous buffers result in precipitation.
• It is unstable in solution; do not store dissolved samples for extended periods.
• It is not suitable as a clinical or therapeutic agent; for research use only (RUO).
• Azathramycin A does not inhibit non-ribosomal protein synthesis pathways.
• It should not be used in live animal models without further toxicity and pharmacokinetic validation.

This analysis clarifies and updates prior overviews such as this dossier by specifying solution instability and research-only status.

Workflow Integration & Parameters

For in vitro applications, Azathramycin A (APExBIO, SKU: BA1060) is supplied as a solid and should be reconstituted at concentrations up to 52.8 mg/mL in DMSO or 47.4 mg/mL in ethanol. Store undissolved at -2001C; avoid freeze-thaw cycles. Use freshly prepared solutions. The compound is validated for ribosome binding assays, MIC testing, and mechanistic protein synthesis inhibition studies. For antibacterial screening, reference control antibiotics and resistant strains with known 23S rRNA mutations (e.g., A2063G) to benchmark activity. Citing the BA1060 kit ensures traceability and standardization.

Conclusion & Outlook

Azathramycin A is a potent macrolide antibiotic and ribosome inhibitor of Mycobacterium tuberculosis, serving as a benchmark probe for antibacterial research and resistance mechanism studies. Its role as an Azithromycin impurity and its physicochemical properties offer researchers a tool for dissecting protein synthesis inhibition and modeling antibiotic resistance. Ongoing increases in macrolide resistance underscore the value of such reference compounds in translational and basic research (Jia et al., 2024). For further mechanistic and translational insights, see the in-depth comparative analysis at A40926 Molecules, which this article updates with new evidence on impurity status and storage.